Pay in 4 interest-free payments of $23.80 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
InChi: InChI=1S/C4H10NO5P/c5-3(4(6)7)1-2-11(8
PubMed PMID: 20003343
for use in fluorescence microscopy
In the dimer
In the vena cava protocol
Sorafenib Tosylate - CAS# 475207-59-1 rizine dihydrochloride InChi: InChI=1S/C4H10NO5P/c5-3(4(6)7)1-2-11(8Sorafenib, also known as BAY 43 9006, is a synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF MEK ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR 2 PDGFR beta signaling cascade, thereby blocking tumor angiogenesis. Sorafenib was approved in 2005 for use in the treatment of advanced renal cancer. Product
US$ 355.00
US$ 1220.00
US$ 175.00
US$ 497.50
US$ 497.50
US$ 2450.00
US$ 315.48
US$ 1220.00
US$ 1083.47
US$ 1240.00